FENCFennec Pharmaceuticals Inc.
$10.07+15% 1Y
$10.07
$5.7752 weeks$12.78
Is the price fair?
What FENC's price assumes
Fennec Pharmaceuticals Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 6.61× revenue.
6.61
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 9.23
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 9.23
- EV / EBIToperating margin −1.9%: the multiple describes the denominator
- not meaningful
- Market capitalisation35.1 million shares, counted Aug 11, 2026
- $353M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.